Developments IntraBio posts positive Phase 3 trial in Niemann-Pick disease Type C Closely-held IntraBio reported positive topline results from a Phase 3 clinical trial, showing IB1001 significantly improved symptoms, functioning, quality of life, and cognition in pediatric and adult patients with... June 29, 2023